Kalkine has a fully transformed New Avatar.

Switch to Old version
1800-272-662
Shopping Cart 0
countryflagAU
Login

Beauty Health Co

Consumer Defensive US SKIN

1.13USD
-0.05(4.24%)

Last update at 2026-03-10T20:03:00Z

Day Range

1.121.20
LowHigh

52 Week Range

1.359.73
LowHigh

Fundamentals

  • Previous Close 1.18
  • Market Cap311.55M
  • Volume665594
  • P/E Ratio-
  • Dividend Yield-%
  • EBITDA-93.53100M
  • Revenue TTM393.12M
  • Revenue Per Share TTM3.04
  • Gross Profit TTM 250.34M
  • Diluted EPS TTM-0.71

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Analyst Recommendations

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Income before tax 45.03M -377.35000M -38.48300M -2.93500M 0.01000M
Minority interest - - - - -
Net income 44.38M -375.10800M -29.17500M -1.63800M -0.31700M
Selling general administrative 106.10M 98.69M 30.65M 26.66M 17.77M
Selling and marketing expenses 160.08M 111.58M 50.32M 61.77M 42.74M
Gross profit 250.34M 181.83M 67.20M 106.51M 72.97M
Reconciled depreciation 22.02M 21.28M 14.53M 13.94M 11.50M
Ebit -24.28000M -36.63900M -17.18200M 13.46M 10.05M
Ebitda -16.75500M -88.18900M -2.82800M 27.88M 21.55M
Depreciation and amortization 7.53M -51.55000M 14.35M 14.42M 11.50M
Non operating income net other 82.70M -328.93400M - - -
Operating income -24.28000M -36.63900M -17.18200M 13.46M 10.06M
Other operating expenses 390.16M 296.73M 136.27M 153.16M 102.25M
Interest expense 13.39M 11.78M 21.27M 17.09M 10.05M
Tax provision 0.65M -2.24200M -9.30800M -1.29700M 0.33M
Interest income 9.18M - 36.69M - -
Net interest income -4.21700M -11.77700M -21.27500M -17.09200M -10.04900M
Extraordinary items - - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense 0.65M -2.24200M -9.30800M -1.29700M 0.33M
Total revenue 365.88M 260.09M 119.09M 166.62M 112.31M
Total operating expenses 274.62M 218.47M 84.38M 93.05M 62.91M
Cost of revenue 115.54M 78.26M 51.89M 60.11M 39.34M
Total other income expense net 69.31M -340.71100M -21.30100M -16.39700M -0.00100M
Discontinued operations - - - - -
Net income from continuing ops 44.38M -375.10800M -29.17500M -1.63800M -0.31700M
Net income applicable to common shares 44.38M -375.10800M -29.91500M -2.35900M -90.92900M
Preferred stock and other adjustments - - - - -
Breakdown 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Type yearly yearly yearly yearly yearly
Date 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Total assets 929.11M 1008.91M 1218.81M 222.84M 226.35M
Intangible assets 62.12M 46.39M 56.01M 50.94M 60.29M
Earning assets - - - - -
Other current assets 13.88M 26.70M 12.32M 3.22M 3.71M
Total liab 869.72M 837.43M 916.51M 252.79M 227.56M
Total stockholder equity 59.39M 171.48M 302.30M -29.96000M -1.20800M
Deferred long term liab - 2.01M 3.56M 2.40M -
Other current liab 62.88M 37.01M 3.71M 11.93M 0.14M
Common stock 0.01M 0.01M 0.02M 376.49M -
Capital stock 0.01M 0.01M 0.02M 0.00000M 0.00000M
Retained earnings -478.86700M -374.32800M -418.71200M -43.60400M -14.42900M
Other liab - 17.48M 97.38M 5.84M 8.89M
Good will 125.82M 124.59M 123.69M 98.53M 98.52M
Other assets - 15.01M 7.04M 5.08M 2.57M
Cash 523.02M 568.20M 901.89M 9.49M 7.31M
Cash and equivalents - - - - -
Total current liabilities 115.01M 73.11M 76.44M 30.93M 37.82M
Current deferred revenue 2.76M 0.81M 39.96M - 14.49M
Net debt 229.26M 183.59M -171.97200M 207.05M 182.47M
Short term debt 4.60M 4.96M 3.71M 0.51M 8.93M
Short long term debt - - - 0.51M 8.93M
Short long term debt total 752.29M 751.79M 729.91M 216.54M 189.78M
Other stockholder equity 541.28M 550.32M 722.25M 13.40M 13.19M
Property plant equipment - 33.82M 31.18M 9.19M 10.80M
Total current assets 698.25M 789.10M 1000.89M 59.09M 54.17M
Long term investments - - - 460.10M -
Net tangible assets - 0.50M 122.59M -179.42600M -160.02100M
Short term investments - - - -0.02063M -
Net receivables 70.03M 77.77M 51.42M 23.19M 23.72M
Long term debt 738.37M 734.14M 729.91M 216.02M 180.85M
Inventory 91.32M 116.43M 35.26M 23.20M 19.43M
Accounts payable 44.77M 30.34M 29.05M 18.48M 14.26M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income -3.03600M -4.53000M -1.25700M 0.24M 0.03M
Additional paid in capital - - - - -
Common stock total equity - 0.01M 0.02M 376.49M -
Preferred stock total equity - - - - -
Retained earnings total equity - -374.32800M -418.71200M -38.91380M -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other 16.04M 14.19M 6.71M 4.81M 2.34M
Deferred long term asset charges - - - - -
Non current assets total 230.86M 219.81M 217.91M 163.74M 172.18M
Capital lease obligations 13.92M 17.65M 16.49M 0.00000M 0.42M
Long term debt total - 734.14M 729.91M - -
Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Investments -18.86900M 0.78M -3.81700M -12.48000M -8.44300M
Change to liabilities -1.55300M 34.71M 4.89M 4.31M 4.18M
Total cashflows from investing activities -18.86900M -37.73100M -3.81700M -12.48000M -8.44300M
Net borrowings - 413.02M 19.73M 14.73M 113.63M
Total cash from financing activities -205.24200M 959.03M 18.27M 14.58M 11.16M
Change to operating activities -31.83600M 11.83M -0.38600M 1.08M 1.24M
Net income 44.38M -375.10800M -29.17500M -1.63800M -0.31700M
Change in cash -333.68900M 892.40M 2.18M 3.73M 1.82M
Begin period cash flow 901.89M 9.49M 7.31M 3.58M 1.75M
End period cash flow 568.20M 901.89M 9.49M 7.31M 3.58M
Total cash from operating activities -106.60000M -28.36100M -12.43600M 1.73M -0.89500M
Issuance of capital stock - - - - -
Depreciation 22.02M 21.14M 14.40M 13.88M 11.50M
Other cashflows from investing activities -8.02200M -27.31100M -460.00000M 0.78M -0.55800M
Dividends paid - - 0.00000M 0.00000M 98.71M
Change to inventory -82.09700M -9.44300M -3.21100M -4.76900M -9.79900M
Change to account receivables -32.02500M -31.01300M 3.70M -11.04800M -7.71900M
Sale purchase of stock -160.00000M 188.38M -0.15400M 0.00000M 0.00000M
Other cashflows from financing activities -45.74200M 1189.52M 35.20M 26.58M 114.90M
Change to netincome -42.36400M 292.97M 3.31M -3.88700M -2.85800M
Capital expenditures 17.39M 15.62M 3.82M 10.42M 7.88M
Change receivables -32.02500M -31.01300M - - -
Cash flows other operating -15.81800M 41.59M - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes -330.71100M 892.94M - - -
Change in working capital -140.28300M -18.66400M -2.58200M -7.91200M -9.78000M
Stock based compensation 28.50M 12.42M 0.36M 0.10M 0.06M
Other non cash items -59.42500M 335.62M 8.90M 1.94M 0.66M
Free cash flow -123.99400M -43.97700M -16.25300M -8.69400M -8.78000M

Peer Comparison

Sector: Consumer Defensive Industry: Household & Personal Products

Company Change (USD) Price (USD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
SKIN
Beauty Health Co		 -0.05 4.24% 1.13 - 40.82 1.14 7.64 1.72 -12.1937
PG
Procter & Gamble Company		 0.79 0.51% 156.01 23.58 22.62 4.07 7.24 4.40 16.08
LRLCF
L'Oréal S.A		 -3.74 0.88% 423.31 41.14 34.25 6.52 8.59 6.67 27.76
LRLCY
L’Oreal Co ADR		 -2.5 2.90% 83.68 41.27 33.90 6.56 8.50 6.65 27.67
UNLYF
Unilever PLC		 - -% 65.62 21.17 17.33 2.44 6.76 2.66 12.91

Reports Covered

Stock Research & News

View All

Profile

The Beauty Health Company designs, develops, manufactures, markets, and sells aesthetic technologies and products worldwide. The company's flagship product includes HydraFacial that enhance the skin to cleanse, extract, and hydrate the skin with proprietary solutions and serums. Its products also comprise Syndeo, a Delivery System designs to connects providers to the consumer's preferences to create a more personalized experience; consumables, such as single-use tips, solutions, and serums used to provide a hydrafacial treatment; SkinStylus SteriLock Microsystem, a microneedling device used for the treatment of enhancing appearance of surgical or traumatic hypertrophic scars on the abdomen and facial acne scarring in Fitzpatrick skin types I, II, and III; and Keravive, a treatment for scalp health. The company was founded in 1997 and is headquartered in Long Beach, California.

Beauty Health Co

2165 Spring Street, Long Beach, CA, United States, 90806

Key Executives

Name Title Year Born
Mr. Brenton L. Saunders J.D. Exec. Chairman 1970
Ms. Liyuan Woo Chief Financial Officer 1972
Mr. Daniel Copell Watson Exec. VP of Americas Sales 1962
Mr. Andrew Stanleick Pres, CEO & Director 1971
Eduardo Rodriguez Sr. Director of M&A and Investor Relations NA
Mr. Paul Bokota VP & Gen. Counsel NA
Ms. Kellie Sears Chief HR Officer NA
Dr. Jwala Karnik M.D. Exec. VP of Strategy & Partnership NA
Mr. Benjamin C. Baum Chief Experience Officer 1973
Mr. Mingo Ku Pres of North Asia NA

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.